{'fraction_non_alphanumeric': 0.032758620689655175, 'fraction_numerical': 0.013793103448275862, 'mean_word_length': 5.916666666666667, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
54 Long-term radiopacity of a polymer aneurysm treatment device: neurocure® liquid embolic

Conclusions In this retrospective cohort, aSAH the COVID-19 era is associated with delayed presentation and attendant increases in cerebral vasospasm, delayed cerebral ischemia, aneurysmal re-rupture, and increased in-hospital mortality/hos-pice disposition. These data demonstrate a novel association between the COVID-19 pandemic and aneurysmal subarachnoid hemorrhage care, highlighting increases in overall mortal-ity in non-COVID-19 associated disease driven by the ongoing pandemic.